|
Bocanegra C, Alvarez-Martinez MJ, Arsuaga Vicente M, Belhassen-Garcia M, Chamorro Tojeiro S, Camprubi-Ferrer D, Fernandez Soto P, Garcia Vazquez E, Herrador Ortiz Z, Martin O, Muro A, Perez Arellano JL, Reguera Gomez M, Salas-Coronas J, Salvador F, Sotillo Gallego J, Sulleiro E, Torrus Tendero D, Velasco Arribas M, Rodriguez Guardado A. Executive summary consensus statement of imported diseases group (GEPI) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Tropical Medicine and International Health (SETMSI), on the diagnostic and treatment of imported schistosomiasis. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Oct;41(8):505-512. doi: 10.1016/j.eimce.2023.02.008. Epub 2023 May 23. PubMed PMID: 37230838.
AÑO: 2023
|
37230838
|
Del Pozo-Valero M, Corton M, Lopez-Rodriguez R, Mahillo-Fernandez I, Ruiz-Hornillos J, Minguez P, Villaverde C, Perez-Tomas ME, Barreda-Sanchez M, Mancebo E; STOP_Coronavirus Study Group; Paz-Artal E, Guillen-Navarro E, Almoguera B, Ayuso C. Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years. Geroscience. 2023 Feb;45(1):543-553. doi: 10.1007/s11357-022-00666-5. Epub 2022 Oct 3. PubMed PMID: 36184726; PubMed Central PMCID: PMC9527133.
AÑO: 2023; IF: 5.3
|
|
Sojo-Dorado J, Lopez-Hernandez I, Hernandez-Torres A, Retamar-Gentil P, Merino de Lucas E, Escola-Verge L, Bereciartua E, Garcia-Vazquez E, Pintado V, Boix-Palop L, Natera-Kindelan C, Sorli L, Borrell N, Amador-Prous C, Shaw E, Jover-Saenz A, Molina J, Martinez-Alvarez RM, Duenas CJ, Calvo-Montes J, Lecuona M, Pomar V, Borreguero I, Palomo-Jimenez V, Docobo-Perez F, Pascual A, Rodriguez-Bano J. Effectiveness of fosfomycin trometamol as oral step-down therapy for bacteraemic urinary tract infections due to MDR Escherichia coli: a post hoc analysis of the FOREST randomized trial. J Antimicrob Chemother. 2023 Jul 5;78(7):1658-1666. doi: 10.1093/jac/dkad147. PubMed PMID: 37260299; PubMed Central PMCID: PMC10775153.
AÑO: 2023; IF: 3.9
|
|
Castro-Santos P, Rojas-Martinez A, Riancho JA, Lapunzina P, Flores C, Carracedo A, Diaz-Pena R; Scourge Cohort Group. HLA-A*11:01 and HLA-C*04:01 are associated with severe COVID-19. HLA. 2023 Dec;102(6):731-739. doi: 10.1111/tan.15160. Epub 2023 Aug 1. PubMed PMID: 37528566.
AÑO: 2023; IF: 5.9
|
|
Hidalgo-Tenorio C, Sadyrbaeva-Dolgova S, Enriquez-Gomez A, Munoz P, Plata-Ciezar A, Miro JM, Alarcon A, Martinez-Marcos FJ, Loeches B, Escrihuela-Vidal F, Vinuesa D, Herrero C, Boix-Palop L, Del Mar Arenas M, Vazquez EG, de Las Revillas FA, Pasquau J; EN-DALBACEN study group. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci. Int J Antimicrob Agents. 2023 Sep;62(3):106918. doi: 10.1016/j.ijantimicag.2023.106918. Epub 2023 Jul 11. PubMed PMID: 37442488.
AÑO: 2023; IF: 4.9
|